Member CPD Events

The first ECOV seminar for 2019 will provide early career optometrists with a practical overview of diagnosing patients who have less obvious causes of vision loss such as neurodegenerations, retinal and optic nerve dystrophies and autoimmune, inflammatory and paraneoplastic related disease. This will include discussion around non-glaucomatous visual field loss, acquired colour vision defects and electrodiagnostic and imaging tools useful in diagnosing neural aetiologies to vision loss. 


Date: Tuesday 19 March, 2019

Time: Dinner and drinks from 6.00 pm. Seminar  6.30 pm – 8.45 pm

Venue: Optometry Victoria, 1st Floor, 28 Drummond St, Carlton

Cost: Free to Optometry Victoria Members

CPD Points: Participants will receive 6 clinical CPD points for attending (with assessment). 

Registration is essential. Book online through the member portal here (click on upcoming events and CPD/Face to face) or contact Optometry Victoria on or call (03) 9652 9100.

More about our speaker 

Dr Anne Weymouth  BOptom, CertOcTher, PhD.

Anne currently works as a consultant electrophysiologist in a private ophthalmology clinic as well as in independent optometry practice. Her patient base includes those with dystrophies, toxicities and neurodegenerations, those with autoimmune or paraneoplastic retinopathies as well as babies and young children. She also consults in occupational assessments of visual function.   Recent research interests involve investigating hyperspectral imaging in retinal disease as well as clinical trials assessing the potential for retinal toxicity in novel therapeutic agents, currently a therapy for multiple sclerosis.    

Anne is a Director on the board of Optometry Victoria, a member of the International Society for Clinical Electrophysiology of Vision, a Credentialed Optometrist for CASA and a Fellow of the Department of Optometry and Vision Sciences at the University of Melbourne, the Royal Victorian Eye and Ear Hospital and the Australian College of Optometry, and supervises postgraduate research in the University of Melbourne’s Department of Ophthalmology.